Inclusion and exclusion criteria
We selected all PRIDE Study participants with an estimated date of delivery in 2012-2019 (N = 9,054) and participants in The Dutch Pregnancy Drug Register with an estimated date of delivery in 2014-2019 (N = 3,911). Participants included in both cohorts were included only once, retaining the record with most complete information. Participants who were diagnosed with early-onset preeclampsia (pathophysiology differs from late-onset preeclampsia)18 or who delivered before gestational week 34 (not at risk for the outcome of interest) were excluded.